JP2020504135A5 - - Google Patents

Download PDF

Info

Publication number
JP2020504135A5
JP2020504135A5 JP2019536859A JP2019536859A JP2020504135A5 JP 2020504135 A5 JP2020504135 A5 JP 2020504135A5 JP 2019536859 A JP2019536859 A JP 2019536859A JP 2019536859 A JP2019536859 A JP 2019536859A JP 2020504135 A5 JP2020504135 A5 JP 2020504135A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
hvr
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019536859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020504135A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/012694 external-priority patent/WO2018129400A1/en
Publication of JP2020504135A publication Critical patent/JP2020504135A/ja
Publication of JP2020504135A5 publication Critical patent/JP2020504135A5/ja
Pending legal-status Critical Current

Links

JP2019536859A 2017-01-06 2018-01-05 慢性閉塞性肺障害を処置するための方法および組成物 Pending JP2020504135A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762443591P 2017-01-06 2017-01-06
US62/443,591 2017-01-06
PCT/US2018/012694 WO2018129400A1 (en) 2017-01-06 2018-01-05 Methods and compositions for treating chronic obstructive pulmonary disorder

Publications (2)

Publication Number Publication Date
JP2020504135A JP2020504135A (ja) 2020-02-06
JP2020504135A5 true JP2020504135A5 (enExample) 2021-02-12

Family

ID=62790958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019536859A Pending JP2020504135A (ja) 2017-01-06 2018-01-05 慢性閉塞性肺障害を処置するための方法および組成物

Country Status (4)

Country Link
US (1) US20190338027A1 (enExample)
EP (1) EP3565597A4 (enExample)
JP (1) JP2020504135A (enExample)
WO (1) WO2018129400A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6825909B2 (ja) 2014-02-28 2021-02-03 アラコス インコーポレイテッド シグレック−８関連疾患を処置するための方法および組成物
HK1254432A1 (zh) 2015-06-17 2019-07-19 Allakos Inc. 用於治疗纤维性疾病的方法和组合物
US10604577B2 (en) 2015-10-22 2020-03-31 Allakos Inc. Methods and compositions for treating systemic mastocytosis
BR112019022912A2 (pt) 2017-05-05 2020-05-26 Allakos Inc. Métodos e composições para tratar doenças oculares alérgicas
MX2022001403A (es) * 2019-08-02 2022-03-25 Allakos Inc Metodos de administracion de anticuerpos anti-siglec-8 y corticosteroides.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4860877B2 (ja) * 2000-03-07 2012-01-25 ジョンズ・ホプキンス・ユニバーシティ シアロアドへジンファクター−２抗体
KR20210125114A (ko) * 2013-12-09 2021-10-15 알라코스 인크. 항-Siglec-8 항체 및 그의 사용 방법
JP6825909B2 (ja) * 2014-02-28 2021-02-03 アラコス インコーポレイテッド シグレック−８関連疾患を処置するための方法および組成物
HK1254432A1 (zh) * 2015-06-17 2019-07-19 Allakos Inc. 用於治疗纤维性疾病的方法和组合物

Similar Documents

Publication Publication Date Title
JP2023515271A5 (enExample)
US11597768B2 (en) Immunotherapy for hepatocellular carcinoma
JP2018108081A5 (enExample)
US11459384B2 (en) Biopharmaceutical compositions
JP2013538553A5 (enExample)
JP2017507945A5 (enExample)
JP2021521843A5 (enExample)
JP2021524256A5 (enExample)
JP2018527887A5 (enExample)
JP2021526534A5 (enExample)
JP2018535648A5 (enExample)
JP2021519295A5 (enExample)
JP2017534577A5 (enExample)
JP2018525332A5 (enExample)
JP2008511542A5 (enExample)
RU2018100820A (ru) ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА И АНТИТЕЛА С СОЗРЕВШЕЙ АФФИННОСТЬЮ ПРОТИВ FcRH5 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2016533335A5 (enExample)
JP2012504634A5 (enExample)
RU2011117237A (ru) АНТИТЕЛА ПРОТИВ Notch2 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2021534797A5 (enExample)
JP2009533367A5 (enExample)
JP2020522280A5 (enExample)
JP2021511387A5 (enExample)
WO2019195313A1 (en) Anti-vegf antagonist and pedf agonist constructs and uses thereof
JP2018533569A5 (enExample)